Sutro Biopharma (STRO) EBT Margin (QoQ) (2017 - 2025)

Sutro Biopharma (STRO) EBT Margin (QoQ) (2017 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Sutro Biopharma 339.58 Mn 175.24 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -12,318.00
Sep 30, 2025 -56,851.00
Jun 30, 2025 37,060.00
Mar 31, 2025 8,461.00
Dec 31, 2024 9,934.00
Sep 30, 2024 -38,585.00
Jun 30, 2024 26,075.00
Mar 31, 2024 -48,873.00
Dec 31, 2023 32,156.00
Sep 30, 2023 8,820.00
Jun 30, 2023 2,324.00
Mar 31, 2023 898.00
Dec 31, 2022 -32,327.00
Sep 30, 2022 619.00
Jun 30, 2022 57,953.00
Mar 31, 2022 -30,537.00
Dec 31, 2021 498.00
Sep 30, 2021 -34,089.00
Jun 30, 2021 11,224.00
Mar 31, 2021 10,745.00